Aron H Lichtman Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2018	Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy.
1/2018	Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aron H Lichtman Research Topics

Disease

34	Pain (Aches) 01/2024 - 12/2002
20	Hyperalgesia 10/2023 - 06/2004
20	Neuralgia (Stump Neuralgia) 01/2020 - 10/2004
13	Neoplasms (Cancer) 01/2023 - 09/2007
13	Hypothermia 01/2020 - 07/2002
12	Catalepsy 01/2020 - 08/2002
7	Edema (Dropsy) 03/2013 - 06/2004
6	Tobacco Use Disorder (Nicotine Dependence) 04/2024 - 01/2017
6	Inflammation (Inflammations) 01/2023 - 07/2004
6	Neurocognitive Disorders (Clerambault Syndrome) 01/2022 - 01/2016
6	Nausea 11/2021 - 01/2012
5	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 11/2002
5	Neuroinflammatory Diseases 12/2021 - 11/2011
5	Peripheral Nervous System Diseases (PNS Diseases) 11/2021 - 11/2016
4	Substance-Related Disorders (Drug Abuse) 11/2023 - 11/2002
4	Diarrhea 01/2022 - 10/2011
4	Hypersensitivity (Allergy) 01/2021 - 12/2010
3	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022 - 01/2011
3	Weight Loss (Weight Reduction) 01/2022 - 05/2005
3	Vomiting 11/2021 - 01/2012
3	Body Weight (Weight, Body) 02/2020 - 05/2005
3	Chronic Pain 01/2018 - 12/2010
2	Wounds and Injuries (Trauma) 10/2022 - 01/2017
2	Reperfusion Injury 10/2022 - 04/2012
2	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021 - 01/2017
2	Anhedonia 09/2020 - 01/2017
2	Multiple Sclerosis 01/2018 - 07/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2018
2	Cancer Pain 01/2018 - 08/2017
2	Seizures (Absence Seizure) 01/2017 - 05/2003
2	Chronic Disease (Chronic Diseases) 01/2017 - 01/2016
2	Central Nervous System Diseases (CNS Diseases) 01/2017 - 01/2016
2	Pruritus (Itching) 04/2016 - 04/2009
2	Cognitive Dysfunction 01/2016 - 08/2011
2	Memory Disorders (Memory Loss) 07/2014 - 01/2007
2	Hemorrhage 06/2013 - 09/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2011 - 08/2007
2	Tremor (Tremors) 10/2011 - 09/2006
2	Visceral Pain 11/2009 - 04/2009

Drug/Important Bio-Agent (IBA)

32	CannabinoidsIBA 01/2024 - 08/2002
25	EndocannabinoidsIBA 12/2023 - 12/2002
24	EnzymesIBA 12/2023 - 12/2002
20	Dronabinol (THC)FDA LinkGeneric 11/2021 - 08/2002
17	anandamide (arachidonylethanolamide)IBA 01/2023 - 12/2002
16	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2024 - 06/2004
15	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 10/2022 - 06/2004
12	Monoacylglycerol LipasesIBA 01/2024 - 12/2010
10	Opioid Analgesics (Opioids)IBA 01/2022 - 11/2002
8	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2022 - 11/2002
8	AmidesIBA 01/2021 - 12/2002
7	Nicotine FDA Link 04/2024 - 01/2013
7	Morphine (MS Contin)FDA LinkGeneric 01/2021 - 10/2011
7	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 12/2002
7	JZL 184IBA 01/2018 - 09/2011
7	CarrageenanIBA 01/2017 - 06/2004
6	Analgesics (Analgesic Drugs)IBA 01/2024 - 09/2011
6	LipidsIBA 12/2021 - 12/2002
6	RimonabantIBA 10/2011 - 07/2002
5	MJN110IBA 01/2024 - 02/2015
5	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2023 - 03/2016
5	Naloxone (Narcan)FDA LinkGeneric 01/2022 - 10/2011
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 11/2016
5	Formaldehyde (Formol)FDA Link 01/2020 - 06/2004
5	Cannabinoid Receptor AgonistsIBA 06/2018 - 07/2010
4	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2018 - 02/2013
4	PF 3845IBA 08/2015 - 04/2012
4	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 04/2014 - 05/2007
3	N-oleoylglycineIBA 01/2021 - 01/2020
3	Trans-Activators (Trans-Acting Factor)IBA 01/2021 - 01/2017
3	LigandsIBA 11/2020 - 04/2012
3	3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA 01/2020 - 02/2011
3	Gabapentin (Neurontin)FDA LinkGeneric 06/2018 - 12/2010
3	LipopolysaccharidesIBA 12/2017 - 07/2010
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2014 - 04/2009
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2014 - 01/2008
3	Diclofenac (SR 38)FDA LinkGeneric 09/2014 - 01/2008
2	Alanine (L-Alanine)FDA Link 11/2023 - 09/2020
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2023 - 09/2020
2	Urea (Carbamide)FDA LinkGeneric 10/2022 - 01/2018
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 12/2021 - 12/2017
2	nabilone (Cesamet)FDA Link 11/2021 - 01/2014
2	Viral ProteinsIBA 01/2021 - 03/2013
2	Opiate AlkaloidsIBA 11/2020 - 04/2016
2	CytokinesIBA 11/2020 - 09/2011
2	Lithium ChlorideIBA 02/2020 - 03/2016
2	Sucrose (Saccharose)IBA 01/2020 - 01/2017
2	CannabidiolIBA 01/2018 - 08/2017
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018 - 07/2014
2	nabiximols (Sativex)IBA 01/2018 - 08/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017 - 01/2017
2	HydrolasesIBA 01/2017 - 11/2004
2	piperidineIBA 08/2015 - 05/2015
2	AcidsIBA 04/2014 - 07/2010
2	SmokeIBA 12/2012 - 01/2011
2	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 10/2011 - 12/2010
2	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 07/2010 - 02/2008

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 04/2024 - 11/2016
8	Therapeutics 01/2023 - 01/2014
8	Analgesia 01/2018 - 11/2004